Page last updated: 2024-09-04

naproxen and Muscular Dystrophy, Duchenne

naproxen has been researched along with Muscular Dystrophy, Duchenne in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordish-Dressman, H; Miglietta, D; Miller, BK; Nagaraju, K; Ongini, E; Phadke, A; Quinn, JL; Tatem, KS; Uaesoontrachoon, K; Van Der Meulen, JH; Yu, Q1
Clementi, E; De Palma, C; Miglietta, D; Ongini, E; Pisa, V; Sciorati, C; Vergani, B; Villa, A1

Other Studies

2 other study(ies) available for naproxen and Muscular Dystrophy, Duchenne

ArticleYear
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
    Human molecular genetics, 2014, Jun-15, Volume: 23, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests; Hindlimb; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Naproxen; Nitric Oxide Donors; Prednisolone

2014
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
    Orphanet journal of rare diseases, 2015, Aug-22, Volume: 10

    Topics: Animals; Biological Availability; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Naproxen; Nitric Oxide Donors

2015